LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

LLY

733.18

-2.5%↓

JNJ

153.97

-1.02%↓

UNH

380.38

-1.39%↓

ABBV

184.25

-0.64%↓

ABT

133.26

-0.42%↓

Search

Design Therapeutics Inc

Fechado

3.47 -1.14

Visão Geral

Variação de preço das ações

24h

Atual

Mín

3.43

Máximo

3.5

Indicadores-chave

By Trading Economics

Rendimento

-612K

-14M

EPS

-0.24

Funcionários

54

EBITDA

-452K

-17M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+142.86% upside

Dividendos

By Dow Jones

Próximos Ganhos

13 de mai. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-14M

264M

Abertura anterior

4.61

Fecho anterior

3.47

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

Design Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

11 de mai. de 2025, 23:48 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11 de mai. de 2025, 23:46 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11 de mai. de 2025, 23:45 UTC

Conversa de Mercado

Oil Rises Amid Improved Market Mood -- Market Talk

11 de mai. de 2025, 23:38 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Aristocrat Has Significant Firepower for M&A -- Market Talk

11 de mai. de 2025, 23:36 UTC

Conversa de Mercado

Global Markets Uncertain About US-China Trade News -- Market Talk

11 de mai. de 2025, 23:35 UTC

Conversa de Mercado

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11 de mai. de 2025, 23:33 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11 de mai. de 2025, 23:32 UTC

Principais Notícias

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11 de mai. de 2025, 22:44 UTC

Conversa de Mercado

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11 de mai. de 2025, 22:33 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11 de mai. de 2025, 20:19 UTC

Principais Notícias

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11 de mai. de 2025, 16:00 UTC

Principais Notícias

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11 de mai. de 2025, 11:00 UTC

Principais Notícias

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11 de mai. de 2025, 08:00 UTC

Principais Notícias

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11 de mai. de 2025, 01:00 UTC

Principais Notícias

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11 de mai. de 2025, 01:00 UTC

Principais Notícias

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10 de mai. de 2025, 21:54 UTC

Principais Notícias

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10 de mai. de 2025, 17:12 UTC

Principais Notícias

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10 de mai. de 2025, 15:41 UTC

Principais Notícias

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10 de mai. de 2025, 12:00 UTC

Principais Notícias

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10 de mai. de 2025, 09:30 UTC

Principais Notícias

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10 de mai. de 2025, 08:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

10 de mai. de 2025, 03:52 UTC

Principais Notícias

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9 de mai. de 2025, 23:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9 de mai. de 2025, 22:06 UTC

Conversa de Mercado

Arm Holdings Remains a Strong Growth Story -- Market Talk

9 de mai. de 2025, 21:37 UTC

Principais Notícias

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9 de mai. de 2025, 21:10 UTC

Principais Notícias

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9 de mai. de 2025, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

9 de mai. de 2025, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

9 de mai. de 2025, 20:42 UTC

Principais Notícias

Stocks Get a Break From Trade Chaos -- WSJ

Comparação entre Pares

Variação de preço

Design Therapeutics Inc Previsão

Preço-alvo

By TipRanks

142.86% parte superior

Previsão para 12 meses

Média 8.5 USD  142.86%

Máximo 12 USD

Mínimo 5 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Design Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

1

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

3.26 / 3.63Suporte e Resistência

Curto Prazo

Very Strong Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.